Predictors of mortality among tuberculosis/HIV-coinfected persons in southwest ethiopia: A case-control study

Journal of the International Association of Providers of AIDS Care

Volumn 14, Issue 3, 2015, Pages 269-273

  Deribe, Kebede ^a   Yami, Alemeshet ^a   Deribew, Amare ^a   Mesfin, Nebiyu ^a,b   Colebunders, Robert ^c,d   Van Geertruyden, Jean Pierre ^c   Woldie, Mirkuziemd ^a   Maja, Todd ^e  

^a JIMMA UNIVERSITY   (Ethiopia)

^b UNIVERSITY OF GONDAR   (Ethiopia)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^e UNIVERSITY OF SOUTH AFRICA   (South Africa)

Author keywords

Ethiopia; mortality; TB HIV coinfection; tuberculosis

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADOLESCENT; ADULT; BLOOD; CASE CONTROL STUDY; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; COMPLICATION; EPIDEMIOLOGY; ETHIOPIA; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV INFECTIONS; HUMAN; MALE; MIDDLE AGED; MIXED INFECTION; MORTALITY; TUBERCULOSIS; YOUNG ADULT;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CASE-CONTROL STUDIES; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; COINFECTION; ETHIOPIA; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; TUBERCULOSIS; YOUNG ADULT;

EID: 84930319403     PISSN: 23259574     EISSN: 23259582     Source Type: Journal    
DOI: 10.1177/2325957413500528     Document Type: Article

References (25)

1. Getahun H, Gunneberg C, Granich R, Nunn P. HIV infection-associated tuberculosis: the epidemiology and the response. Clin Infect Dis. 2010 ; 50 (suppl 3). S201 - S207
2. Lawn SD, Myer L, Harling G, Orrell C, Bekker L G, Wood R. Determinants of mortality and non-death losses from an antiretroviral treatment service in South Africa: implications for program evaluation. Clin Infect Dis. 2006 ; 43 (6). 770-776
3. Moore D, Liechty C, Ekwaru P, et al. Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural Uganda. AIDS. 2007 ; 21 (6). 713-719
4. Mukadi YD, Maher D, Harries A. Tuberculosis case fatality rates in high HIV prevalence populations in sub-Saharan Africa. AIDS. 2001 ; 15 (2). 143-152
5. World Health Organization. Global tuberculosis control: epidemiology, strategy, financing WHO report 2009. http://whqlibdoc.who.int/publications/2009/9789241598866-eng.pdf. Accessed August 10, 2011.
6. World Health Organization. Global tuberculosis control: a short update to the 2009 report. Geneva: World Health Organization; 2009. December 2009. http://www.who.int/tb/publications/global-report/2009/update/tbu-9.pdf. Accessed August 10, 2011.
7. Harries AD, Hargreaves NJ, Kemp J, et al. Deaths from tuberculosis in sub-Saharan African countries with a high prevalence of HIV-1. Lancet. 2001 ; 357 (9267). 1519-1523
8. Worodria W, Massinga-Loembe M, Mazakpwe D, et al. Incidence and predictors of mortality and the effect of tuberculosis immune reconstitution inflammatory syndrome in a cohort of TB/HIV patients commencing antiretroviral therapy. J Acquir Immune Defic Syndr. 2011 ; 58 (1). 32-37
9. Ministry of Health, Ethiopia: Proceedings of the fifth National TB workshop in Jimma University, Ethiopia. October. 2009.
10. Federal Democratic Republic of Ethiopia, Ministry of Health. TB/HIV implementation guideline. Addis Ababa, Ethiopia. 2008.
11. World Health Organization. Global Tuberculosis control. WHO report 2010. http://www.who.int/tb/publications/global-report/2010/en/index.html. Accessed August 10, 2011.
12. Jerene D, Naess A, Lindtjørn B. Antiretroviral therapy at a district hospital in Ethiopia prevents death and tuberculosis in a cohort of HIV patients. AIDS Res Ther. 2006 ; 3: 10
13. Kassa A, Teka A, Shewaamare A, Jerene D.. Incidence of tuberculosis and early mortality in a large cohort of HIV infected patients receiving antiretroviral therapy in a tertiary hospital in Addis Ababa, Ethiopia. Trans R Soc Trop Med Hyg. 2012 ; 106 (6). 363-70
14. Biadgilign S, Reda AA, Digaffe T. Predictors of mortality among HIV infected patients taking antiretroviral treatment in Ethiopia: a retrospective cohort study. AIDS Res Ther. 2012 ; 9 (1). 15
15. Getahun B, Ameni G, Biadgilign S, Medhin G.. Mortality and associated risk factors in a cohort of tuberculosis patients treated under DOTS programme in Addis Ababa, Ethiopia. BMC Infect Dis. 2011 ; 11: 127
16. Federal Ministry of Health Ethiopia. Guideline for the national TB Leprosy Control Programme in Ethiopia Addis Ababa. 2007.
17. Nakanjako D, Mayanja-Kizza H, Ouma J, et al. Tuberculosis and human immunodeficiency virus co-infections and their predictors at a hospital-based HIV/AIDS clinic in Uganda. Int J Tuberc Lung Dis. 2010 ; 14 (12). 1621-1628
18. Lawn SD, Myer L, Bekker LG, Wood R. Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control. AIDS. 2006 ; 20 (12). 1605-1612
19. Zwang J, Garenne M, Kahn K, Collinson M, Tollman SM. Trends in mortality from pulmonary tuberculosis and HIV/AIDS co-infection in rural South Africa (Agincourt). Trans R Soc Trop Med Hyg. 2007 ; 101 (9). 893-898
20. Makwiza I, Nyirenda L, Bongololo G, Banda T, Chimzizi R, Theobald S. Who has access to counseling and testing and anti-retroviral therapy in Malawi - an equity analysis. Int J Equity Health. 2009 ; 8: 13
21. Mocroft A, Kirk O, Barton SE, et al. Anaemia is an independent predictive marker for clinical prognosis in HIV-infected patients from across Europe. EuroSIDA study group. AIDS. 1999 ; 13 (8). 943-950
22. Sullivan PS, Hanson DL, Chu SY, Jones JL, Ward JW. Epidemiology of anemia in human immunodeficiency virus (HIV)-infected persons: results from the multistate adult and adolescent spectrum of HIV disease surveillance project. Blood. 1998 ; 91 (1). 301-308
23. Moore RD, Keruly JC, Chaisson RE. Anemia and survival in HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1998 ; 19 (1). 29-33
24. Tang A M, Forrester J, Spiegelman D, Knox T A, Tchetgen E, Gorbach S L. Weight loss and survival in HIV-positive patients in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2002 ; 31 (2). 230-236
25. Paton N I, Sangeetha S, Earnest A, Bellamy R. The impact of malnutrition on survival and the CD4 count response in HIV-infected patients starting antiretroviral therapy. HIV Med. 2006 ; 7 (5). 323-330